Skip to content

Sequenom, Inc. v. Ariosa Diagnostics, Inc.

Petition for certiorari denied on June 27, 2016

Docket No. Argument Opinion Vote Author Term
15-1182 N/A N/A N/A N/A OT 2015

Issue: Whether a novel method is patent-eligible where: (1) a researcher is the first to discover a natural phenomenon; (2) that unique knowledge motivates him to apply a new combination of known techniques to that discovery; and (3) he thereby achieves a previously impossible result without preempting other uses of the discovery.

DateProceedings and Orders (key to color coding)
02/18/2016Application (15A871) to extend the time to file a petition for a writ of certiorari from March 1, 2016 to April 1, 2016, submitted to The Chief Justice.
02/22/2016Application (15A871) granted by The Chief Justice extending the time to file until April 1, 2016.
03/21/2016Petition for a writ of certiorari filed. (Response due April 20, 2016)
03/28/2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for petitioner.
03/28/2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent Ariosa Diagnostics, Inc. ("Ariosa").
03/30/2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent DNA Diagnostics Center, Inc.("DDC").
03/31/2016Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for respondent Natera, Inc..
03/31/2016Order extending time to file response to petition to and including May 20, 2016, for all respondents.
04/01/2016Brief amici curiae of Eli Lilly and Company, et al. filed.
04/15/2016Brief amicus curiae of The Chartered Institute of Patent Attorneys filed.
04/18/2016Brief amicus curiae of Intellectual Property Owners Association filed.
04/19/2016Brief amicus curiae of Dr. Ananda Mohan Chakrabarty filed.
04/19/2016Brief amici curiae of BioIndustry Association, et al. filed.
04/19/2016Brief amicus curiae of New York Intellectual Property Law Association filed.
04/20/2016Brief amicus curiae of Metabolon, Inc. filed.
04/20/2016Brief amicus curiae of Coalition for 21st Century Medicine filed.
04/20/2016Brief amicus curiae of Novartis AG filed.
04/20/2016Brief amicus curiae of Microsoft Corporation filed.
04/20/2016Brief amici curiae of Professor Jeffrey A. Lefstin, et al. filed.
04/20/2016Brief amicus curiae of Murgitroyd & Company filed.
04/20/2016Brief amici curiae of Biotechnology Innovation Organization, et al. filed.
04/20/2016Brief amici curiae of Amarantus Bioscience Holdings, Inc., et al. filed.
04/20/2016Brief amici curiae of Population Diagnostics, Inc., et al. filed.
04/20/2016Brief amicus curiae of JYANT Technologies, Inc. filed.
04/20/2016Brief amici curiae of 19 Law Professors filed.
04/20/2016Brief amici curiae of Professor Timo Minssen, et al. filed.
04/20/2016Brief amicus curiae of Institute of Professional Representatives before the European Patent Office filed.
04/20/2016Brief amicus curiae of Federal Circuit Bar Association filed.
04/20/2016Brief amici curiae of Wisconsin Alumni Research Foundation, et al. filed.
04/20/2016Brief amicus curiae of Boston Patent Law Association filed.
05/20/2016Brief of respondents Natera, Inc., et al. in opposition filed.
05/20/2016Brief of respondent Ariosa Diagnostics, Inc. in opposition filed.
06/06/2016Reply of petitioner Sequenom, Inc. filed.
06/07/2016DISTRIBUTED for Conference of June 23, 2016.
06/27/2016Petition DENIED.